CSC Spearheads Growth in UK Healthcare with Two New Senior Appointments

CSCCSC (NYSE: CSC) has made two new key appointments to its UK healthcare team. Paul Shannon has been named Medical Director and will be a key interface to NHS clinicians using CSC services. Andy Hall has been appointed Sales Director and will be responsible for leading the growth of new business within CSC's UK healthcare business. These appointments are part of CSC's strategy to further strengthen its position as a leading provider of technology and business solutions in the UK and European healthcare sector.

Gerry O'Keeffe, Vice President for CSC Healthcare in the UK, comments: "These appointments will help CSC spearhead its ambitious and dynamic growth plans within UK healthcare. As a consultant anaesthetist, Paul brings deep clinical experience, continuing to ensure our solutions are developed and deployed from a clinical perspective. Andy's track record of managing and building long-term relationships across the NHS will enable him to play a central role in consolidating and strengthening our business both within the NHS National Programme for IT and the NHS generally."

Paul Shannon's responsibilities will include leading CSC's extensive clinical team, which is involved at all stages of product development and deployment. As a result, Paul will take a pivotal role in ensuring that all solutions delivered are right and appropriate to support healthcare professionals in the delivery of patient care. Additionally, to enhance CSC's collaborative approach to customers, Paul will work closely with senior healthcare decision-makers to understand their challenges and demonstrate how CSC can deliver quality assured systems.

"My key objective is to ensure we create an environment that puts the information clinicians need to do their job at their fingertips," said Paul Shannon. "I am committed to supporting the health service in its drive for high quality and equitable services for all patients and my role at CSC will allow me to make a contribution to achieving that goal. Through the innovative use of technology we can overcome problems of fragmentation in care delivery and help trusts manage costs."

Andy Hall will be responsible for consolidating and expanding CSC's position as the Local Service Provider for the National Programme for IT, in which CSC is deploying solutions to 60% of the NHS in England. Beyond the national programme Andy will also take the lead role in introducing new healthcare solutions. This is part of CSC's continued commitment to deliver solutions that enable trusts to maintain the highest standards of patient care, against a backdrop of quality performance measures and budgetary pressures.

Commenting on his appointment Andy Hall said: "Working with the healthcare team at CSC, my objective will be to develop and grow the business by demonstrating the benefits of joined-up healthcare and how it can be achieved through the deployment of CSC solutions. We will also build upon CSC’s uniquely strong delivery record and partnerships with healthcare clients to further empower front-line staff and drive service improvements."

Paul Shannon qualified in medicine in 1987, becoming a consultant anaesthetist in 1998 at Doncaster Royal Infirmary (DRI). He has held several clinical and managerial positions and gained a MBA in 2003. Paul has operated in national clinical leadership roles at NHS Connecting for Health, the Department of Health, and the independent sector. He continues to practise part-time for the NHS at DRI.

Andy Hall joins CSC after five years with Fujitsu Services in various sales and operational roles. Most notably, he was the Healthcare Business Development Director and the Business Unit Director for their Royal Mail account. Prior to this Andy spent five years with two start-up software companies in the health-care sector, including his position as Sales and Marketing Director at Newchurch (now part of the Tribal Group). Before this Andy held a number of management roles during thirteen years with Xerox.

Related news articles:

  • CSC's Profile

About CSC
CSC is a global leader in providing technology-enabled solutions and services through its lines of business which include Business Solutions & Services and Managed Services and across all major industry sectors. CSC's advanced capabilities include systems design and integration, information technology and business process outsourcing, applications software development, Web and application hosting, mission support and management consulting. Headquartered in Falls Church, Va., CSC has approximately 92,000 employees and reported revenue of $16.0 billion for the 12 months ended October 2, 2009. For more information, visit the company's Web site at www.csc.com.

For further information regarding CSC healthcare solutions in the UK visit www.csc.com/cscalliance

Most Popular Now

Stanford Medicine Study Suggests Physici…

Artificial intelligence-powered chatbots are getting pretty good at diagnosing some diseases, even when they are complex. But how do chatbots do when guiding treatment and care after the diagnosis? For...

OmicsFootPrint: Mayo Clinic's AI To…

Mayo Clinic researchers have pioneered an artificial intelligence (AI) tool, called OmicsFootPrint, that helps convert vast amounts of complex biological data into two-dimensional circular images. The details of the tool...

Testing AI with AI: Ensuring Effective A…

Using a pioneering artificial intelligence platform, Flinders University researchers have assessed whether a cardiac AI tool recently trialled in South Australian hospitals actually has the potential to assist doctors and...

Adults don't Trust Health Care to U…

A study finds that 65.8% of adults surveyed had low trust in their health care system to use artificial intelligence responsibly and 57.7% had low trust in their health care...

AI Unlocks Genetic Clues to Personalize …

A groundbreaking study led by USC Assistant Professor of Computer Science Ruishan Liu has uncovered how specific genetic mutations influence cancer treatment outcomes - insights that could help doctors tailor...

The 10 Year Health Plan: What do We Need…

Opinion Article by Piyush Mahapatra, Consultant Orthopaedic Surgeon and Chief Innovation Officer at Open Medical. There is a new ten-year plan for the NHS. It will "focus efforts on preventing, as...

Deep Learning to Increase Accessibility…

Coronary artery disease is the leading cause of death globally. One of the most common tools used to diagnose and monitor heart disease, myocardial perfusion imaging (MPI) by single photon...

People's Trust in AI Systems to Mak…

Psychologists warn that AI's perceived lack of human experience and genuine understanding may limit its acceptance to make higher-stakes moral decisions. Artificial moral advisors (AMAs) are systems based on artificial...

DMEA 2025 - Innovations, Insights and Ne…

8 - 10 April 2025, Berlin, Germany. Less than 50 days to go before DMEA 2025 opens its doors: Europe's leading event for digital health will once again bring together experts...

Relationship Between Sleep and Nutrition…

Diet and sleep, which are essential for human survival, are interrelated. However, recently, various services and mobile applications have been introduced for the self-management of health, allowing users to record...

New AI Tool Mimics Radiologist Gaze to R…

Artificial intelligence (AI) can scan a chest X-ray and diagnose if an abnormality is fluid in the lungs, an enlarged heart or cancer. But being right is not enough, said...

AI Model can Read ECGs to Identify Femal…

A new AI model can flag female patients who are at higher risk of heart disease based on an electrocardiogram (ECG). The researchers say the algorithm, designed specifically for female patients...